On a per-share basis, the
The results topped
The biotechnology company posted revenue of
Bluebird shares have dropped 33% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a
Copyright by Automated Insights, Inc. All rights reserved., source